Trang H N Pham

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Fine Needle Aspiration

Magnetic Resonance

Prostate Cancer

Top Venues

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Trang H N Pham, Maximilian F Schulze-Hagen, Mohammad Sajjad Rahnamai
Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Trang H N Pham, Maximilian F Schulze-Hagen, Mohammad Sajjad Rahnamai
Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Trang H N Pham, Maximilian F Schulze-Hagen, Mohammad Sajjad Rahnamai
Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study. Cancer reports (Hoboken, N.J.) (2024)
Trang H N Pham, Maximilian F Schulze-Hagen, Mohammad Sajjad Rahnamai
Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Trang H N Pham, Maximilian F Schulze-Hagen, Mohammad Sajjad Rahnamai
Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Trang H N Pham, Maximilian F Schulze-Hagen, Mohammad Sajjad Rahnamai
Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study. Cancer reports (Hoboken, N.J.) 7 (2) (2024)